Canada markets close in 4 hours 18 minutes

Khiron Life Sciences Corp. (KHRN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1450+0.0100 (+7.41%)
As of 11:36AM EDT. Market open.
Full screen
Previous Close0.1350
Open0.1300
Bid0.1400 x 0
Ask0.1450 x 0
Day's Range0.1300 - 0.1500
52 Week Range0.1100 - 0.5000
Volume72,810
Avg. Volume254,225
Market Cap25.993M
Beta (5Y Monthly)N/A
PE Ratio (TTM)0.72
EPS (TTM)0.2000
Earnings DateMay 25, 2022 - May 30, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.80
  • CNW Group

    Khiron achieves United Kingdom Cannabis Sales Volume Growth of 240% in Q1 2022

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), the global medical cannabis leader expanding throughout Europe and Latin America, continues to demonstrate its market dominance in the UK's medical cannabis industry with cannabis sales volume growth of 240% in Q1 2022 compared to the entire 2021 year. This growth is generated by Khiron's end-to-end solution of government regulation, supply chain, distribution, and clinics prescribing Khiron's

  • CNW Group

    Khiron Life Sciences Reports 2021 Fiscal Year End Results

    Khiron Life Sciences Corp. ("Khiron" or the "Corporation") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), the global medical cannabis leader expanding throughout Latin America and Europe, announced today its financial results for the year ended and quarter ended December 31, 2021. These filings are available for review on the Corporation's SEDAR profile at www.sedar.com. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

  • CNW Group

    Khiron to Host YE and Fourth Quarter 2021 Conference Call on May 2, 2022

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMZC), the global medical cannabis leader expanding throughout Latin America and Europe, today announces that it will host a conference call on Monday, May 2nd , 2022 at 10:00 a.m. Eastern Time to discuss its financial results for year ended and quarter ended December 31, 2021. The Company will press release its financial results prior to the conference call. These filings will be available for review